Semin Hear 2006; 27(3): 160-170
DOI: 10.1055/s-2006-947283
Published in 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Pendred Syndrome

Anne C. Madeo1 , 6 , Shannon P. Pryor2 , 6 , Carmen Brewer3 , 6 , Christopher Zalewski4 , 6 , Kelly King5 , 6 , John A. Butman7 , Yandan Yang6 , 8 , Hong-Joon Park9 , Andrew J. Griffith6 , 10
  • 1Genetic Counselor
  • 2Chief, Clinical Otolaryngology
  • 3Chief, Audiology
  • 4Audiologist
  • 5Research Assistant
  • 6National Institutes of Health, Bethesda, Maryland
  • 7Senior Staff Clinician, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland
  • 8Biologist, Laboratory on Gene Structure and Function
  • 9Chief, Soree Ear Clinic, Seoul, Korea
  • 10Chief, Hearing Section
Further Information

Publication History

Publication Date:
17 July 2006 (online)

Preview

ABSTRACT

Hearing loss with an onset in the pre- or perilingual period is a common feature of many hearing loss syndromes, including Pendred syndrome (PS). Although first identified over 100 years ago, PS remains a diagnostic challenge for many clinicians. Its hallmark features include inner ear malformations, most commonly enlarged vestibular aqueducts (EVA), prelingual onset hearing loss and goiter, or enlargement of the thyroid gland. However, these features are not found in all patients with PS, and sometimes they are found in individuals whose clinical evaluations are not consistent with PS. A combination of thorough clinical evaluations and appropriate genetic testing can, however, usually provide an accurate diagnosis. This article presents information on PS, nonsyndromic hearing loss with EVA, the etiology and molecular aspects of these disorders, their epidemiology in various ethnic populations, and their distinguishing clinical and genetic features.

REFERENCES

Anne C MadeoM.S. 

National Institutes of Health

9000 Rockville Pike, Bethesda, MD 20892

Email: Anne.Madeo@nih.gov